EE+ POEM Archive
COVID-19 research briefs: flawed trial of 10-day and 5-day remdesivir and retraction of Lancet trial of hydroxychloroquine
COVID-19 research briefs: flawed trial of 10-day and 5-day remdesivir and retraction of Lancet trial of hydroxychloroquine is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "COVID-19 Research Briefs: Flawed Trial of 10-day and 5-day Remdesivir and Retraction of Lancet Trial of Hydroxychloroquine." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315077/all/COVID_19_research_briefs:_flawed_trial_of_10_day_and_5_day_remdesivir_and_retraction_of_Lancet_trial_of_hydroxychloroquine.
COVID-19 research briefs: flawed trial of 10-day and 5-day remdesivir and retraction of Lancet trial of hydroxychloroquine. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315077/all/COVID_19_research_briefs:_flawed_trial_of_10_day_and_5_day_remdesivir_and_retraction_of_Lancet_trial_of_hydroxychloroquine. Accessed March 26, 2023.
COVID-19 research briefs: flawed trial of 10-day and 5-day remdesivir and retraction of Lancet trial of hydroxychloroquine. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315077/all/COVID_19_research_briefs:_flawed_trial_of_10_day_and_5_day_remdesivir_and_retraction_of_Lancet_trial_of_hydroxychloroquine
COVID-19 Research Briefs: Flawed Trial of 10-day and 5-day Remdesivir and Retraction of Lancet Trial of Hydroxychloroquine [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315077/all/COVID_19_research_briefs:_flawed_trial_of_10_day_and_5_day_remdesivir_and_retraction_of_Lancet_trial_of_hydroxychloroquine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - COVID-19 research briefs: flawed trial of 10-day and 5-day remdesivir and retraction of Lancet trial of hydroxychloroquine
ID - 1315077
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315077/all/COVID_19_research_briefs:_flawed_trial_of_10_day_and_5_day_remdesivir_and_retraction_of_Lancet_trial_of_hydroxychloroquine
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
